1,165 results on '"Bourdin, Arnaud"'
Search Results
152. Study documents
153. The eo-Delphi protocol
154. Brainstorming round 2
155. AsthmaTrain
156. PROTOACCEPT1: Criteria Associated With Patient Willingness to Participate in Biomedical Research
157. COPD-CARhE
158. PROTOACCEPT2
159. Registrations
160. eo-Drive
161. Meta-analysis IAH flow
162. Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects
163. Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study
164. Obesity in women with asthma: Baseline disadvantage plus greater small‐airway responsiveness
165. Construction d’un épithélium bronchique innervé à partir de cellules souches pluripotentes induites iPSC
166. Rheology predicts sputum eosinophilia in patients with muco-obstructive lung diseases
167. Differentiation of Human Induced Pluripotent Stem Cells from Patients with Severe COPD into Functional Airway Epithelium
168. Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: Data from the French pulmonary hypertension registry
169. Lung development, regeneration and plasticity: From disease physiopathology to drug design using induced pluripotent stem cells
170. Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study)
171. Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of paediatric and adult asthma patients
172. Non-typeable Haemophilus influenzae–Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial
173. Using intracellular SCGB1A1-sorted, formalin-fixed club cells for successful transcriptomic analysis
174. QuantiFERON-TB Gold Plus Assay in Patients With Latent vs. Active Tuberculosis in a Low Incidence Setting: Level of IFN-γ, CD4/CD8 Responses, and Release of IL-2, IP-10, and MIG
175. The effect of the COVID-19 pandemic on severe asthma care in Europe: will care change for good?
176. Generation of a healthy heavy smoker patient-derived induced pluripotent stem cell line UHOMi007-A from peripheral blood mononuclear cells
177. Additional file 2 of Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects
178. Additional file 1 of CRISPR/Cas9-mediated gene knockout and interallelic gene conversion in human induced pluripotent stem cells using non-integrative bacteriophage-chimeric retrovirus-like particles
179. Supplementary file on the standard rheometry data, microrheology complementary data, and mucus composition data from Mucus from human bronchial epithelial cultures: rheology and adhesion across length scales
180. sj-docx-1-tar-10.1177_17534666221107313 – Supplemental material for Oral corticosteroid-sparing effects of mepolizumab in severe eosinophilic asthma: evidence from randomized controlled trials and real-world studies
181. Additional file 1 of Artificial intelligence to differentiate asthma from COPD in medico-administrative databases
182. Additional file 1 of Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects
183. Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study
184. LIFE BEYOND LIFE – An Easy Way to Derive Lung Fibroblasts from Cadavers†
185. Software-assisted Computed Tomography Quantification of Airway Remodeling in the Normal Aging Process
186. Obesity in women with asthma: Baseline disadvantage plus greater small‐airway responsiveness.
187. Non-optimal methodology questions indirect treatment comparison of dupilumab vs. other biologics in severe asthma
188. Construction of a 3D innervated bronchial epithelium from human induced pluripotent stem cells iPSC
189. Methods of Sputum and Mucus Assessment for Muco-Obstructive Lung Diseases in 2022: Time to “Unplug” from Our Daily Routine!
190. European Respiratory Society guidelines for the diagnosis of asthma in adults
191. Erratum to: Monocyte CD169 Expression as a Biomarker in the Early Diagnosis of Coronavirus Disease 2019
192. Hedgehog Pathway and its Inhibitors in Chronic Obstructive Pulmonary Disease (COPD)
193. Oral corticosteroid-sparing effects of mepolizumab in severe eosinophilic asthma: evidence from randomized controlled trials and real-world studies
194. Global initiative for asthma: 30 years of promoting evidence‐based asthma care.
195. Roles of Mesenchymal Cells in the Lung: From Lung Development to Chronic Obstructive Pulmonary Disease
196. External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry
197. Defining a Severe Asthma Super-Responder: Findings from a Delphi Process
198. Cardiovascular Events, Sleep Apnoea, and Pulmonary Hypertension in Primary Sjögren’s Syndrome: Data from the French Health Insurance Database
199. Individual trajectory-based care for COPD: getting closer, but not there yet
200. Generation of four severe early-onset chronic obstructive pulmonary disease (COPD) patient-derived induced pluripotent stem cell lines from peripheral blood mononuclear cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.